Clinical Trial

OXINIUM◊ DH Total Hip Arthroplasty Pivotal Study

Name: OXINIUM◊ DH Total Hip Arthroplasty Pivotal Study — clinical trial record (NCT02353377)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to monitor safety of the participants implanted with the OXINIUM◊ DH Hip System up to 10-years post-implantation

Protocol Amendment History 20 amendments

This ClinicalTrials.gov record has been amended 20 times since 2015-01-28; most recent amendment 2026-02-26.

Status change: Withheld → Active, Not Recruiting 2026-02-26

Trial Details

NCT Number	NCT02353377
Lead Sponsor	Smith & Nephew, Inc.
Conditions	Hip Osteoarthritis
Enrollment	413 participants
Start Date	2015-01
Primary Completion	2021-09-21 (estimated)
Study Completion	2030-02-07 (estimated)
Updated on ClinicalTrials.gov	2026-03-19